Remove 2010 Remove Invention Remove Patent Infringement Remove Patent Law
article thumbnail

Moderna sues Pfizer for mRNA Patent Infringement: when optics and profits reveal real issues in modern IP law usage

IPilogue

Michelle Mao is an IPilogue Writer and a 2L JD Candidate at Osgoode Hall Law School. Moderna and Pfizer battle’s over the inventive process of their respective mRNA COVID-19 vaccines revisit the negative associations of profit, monopolies, and optics in patent litigation. This exposes some concerns about our patent laws.

article thumbnail

From Saving the World to Fighting Over IP: Moderna and Pfizer/BioNTech

The IP Law Blog

Moderna was founded in 2010 for the sole purpose of developing mRNA medicines. and the wealthy countries, Moderna announced that it expected its competitors to respect Moderna’s intellectual property and that it would offer patent licenses on reasonable terms to those who asked. Apparently, Pfizer and BioNTech did not ask.

IP 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SpicyIP Weekly Review (March 4-March 10)

SpicyIP

Highlights of the Week Hot-Tubbing in Indian IP Litigation: Delhi High Court Issues Directives in High-Stakes Patent Infringement Case Image from [link] here Recently, the DHC issued directives regarding expert evidence in the Perjeta patent litigation. Justice Prathiba M Singh’s Commentary on patents law released.

article thumbnail

[Guest post] Closing the patent loophole across borders

The IPKat

Patents set themselves apart from other IP rights as inventions are often composed of multiple physical components or steps in a method, which does not necessarily have to exist or be performed at the same time and place. Motorola Inc , [2010] EWHC 118 (Pat). See Menashe Business Mercantile Ltd v. William Hill Org. 2d 1070 (Ct.

Patent 85
article thumbnail

Navigating the Global Intellectual Property Landscape: Key Treaties and Agreements

IIPRD

‘The Paris Convention’, adopted in March 1883 and revised in the years 1900, 1911, 1925, 1934, 1958, 1967, and 1979, comprehensively addresses “patents, utility models, industrial designs, trademarks, service marks, trade names, and geographical indications”. [1] 13] Patent Cooperation Treaty, June 19, 1970, 28 U.S.T. 121; 36 I.L.M.